Search

everythinglearnresearchcommunity

for

Search:↓

The trial will test if YH0618 granule prevents hair loss in breast cancer patients during chemotherapy.

A lotion with Centella asiatica extract reduced hair loss by 41% and increased hair strength without side effects.

New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.

Thermal imaging is a useful non-invasive method to diagnose active inflammation in frontal fibrosing alopecia.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Obesity in the U.S. is largely influenced by diet and exercise, certain medications can improve heart procedures and hair growth, and major teaching hospitals have better patient outcomes.

Researchers found new hair and nail genes, how hair reacts to UV, differences in white and pigmented hair growth, nerve changes in alopecia, treatments for baldness and alopecia, a toenail condition linked to a genetic disorder, and that nail fungus is more common in people with psoriasis.

The meeting discussed various skin conditions, treatments, and unusual cases, highlighting the effectiveness of tetracycline in treating rosacea.

PRP can reduce pain and improve function, but more standardized research is needed.

The microbiome may be linked to hair loss and could be a target for new treatments.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Some medications can improve skin conditions, while lifestyle factors like smoking and drinking may worsen them; treatments like monoclonal antibodies and imiquimod cream show promise for certain skin diseases.

Some vitamins and minerals like vitamin D and iron can help with certain types of hair loss, but more research is needed for others.

Future acne treatments should aggressively target inflammation to prevent scarring.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Effective hair loss assessment requires a mix of precise measurement methods.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.